An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies

Author： Zerra Patricia Cochran Thomas R Franco Vivian I Lipshultz Steven E

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.11, 2013-08, pp. : 1497-1513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia

Current Pharmacogenomics, Vol. 1, Iss. 2, 2003-01 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic considerations for acute lymphoblastic leukemia therapies

By Dulucq Stéphanie Laverdière Caroline Sinnett Daniel Krajinovic Maja

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 5, 2014-05 ,pp. : 699-719

Informa Healthcare

Access to resources Recommend Favorite

Childhood acute lymphoblastic leukemia: Integrating genomics into therapy

By Tasian Sarah K. Loh Mignon L. Hunger Stephen P.

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3577-3590

Blackwell Publishing

Access to resources Recommend Favorite

Polymorphisms in Genes Involved in the Corticosteroid Response and the Outcome of Childhood Acute Lymphoblastic Leukemia

By Isabelle Fleury Melanie Primeau Agnes Doreau Irina Costea Albert Moghrabi Daniel Sinnett Maja Krajinovic

American Journal of PharmacoGenomics, Vol. 4, Iss. 5, 2004-01 ,pp. : 331-341

Adis International

Access to resources Recommend Favorite

Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia

By Lim Joshua Yew-Suang Bhatia Smita Robison Leslie L. Yang Jun J.

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 955-962

Blackwell Publishing

Access to resources Recommend Favorite